IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DAY One Biopharmaceuticals I (DAWN)

CUSIP: 23954D109 | NYSE | Healthcare · Biotechnology | Mid Cap | 441 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AAI Day1 LLC00.0%Fell below 5%Apr 23, 2026No 13F filer matched
13D/AAI Day1 LLC0
0.0% of class · Apr 23, 2026Fell below 5%
No 13F filer matched

Institutional Holders — Q2 2026

IFP Advisors, Inc165
0.0% of portfolio›$3.6K
StyleTurnoverLocationFiled
IFP Advisors, Inc
165$3.6K0.0%GrowthLowTampa, FL2026-07-20